Ilaria Ambaglio

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Clinical significance of somatic mutation in unexplained blood cytopenia.

Clinical significance of somatic mutation in unexplained blood cytopenia.

Journal: Blood

Published: January 18, 2017

Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications.

Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications.

Journal: Leukemia & lymphoma

Published: November 30, 2016

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.

Journal: Blood

Published: May 02, 2016

The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications.

The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications.

Journal: Current opinion in oncology

Published: September 10, 2015

Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy.

Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy.

Journal: Clinical case reports

Published: July 13, 2015

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.

Journal: Blood

Published: March 10, 2015

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.

Journal: Blood

Published: June 28, 2014

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.

Journal: Leukemia

Published: March 19, 2014

Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Journal: Blood

Published: September 14, 2013

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia.

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia.

Journal: Blood

Published: February 02, 2013

Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1.

Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1.

Journal: Haematologica

Published: January 10, 2013

Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool.

Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool.

Journal: Haematologica

Published: January 25, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026